Pharma & Biotech Inside Biotech: Orthocell targets nerve repair gap as US rollout gathers pace By Proactive 07/04
Hardware & electrical equipment Week ahead: Markets brace for CPI, Fed signals, and OPEC+ moves By Proactive 06/04
Pharma & Biotech Lumos Diagnostics targets US breakthrough as FebriDx clearance unlocks billion-dollar opportunity By Proactive 02/04
Aerospace Tech Bytes: SpaceX IPO chatter signals a new era for mega-cap tech listings By Proactive 02/04
Financial Services First Phosphate ‘firing on all cylinders’ to advance flagship project, says Noble By Proactive 01/04
Oil & Gas Prediction market traders price just 22% chance of Strait of Hormuz returning to normal by end of April By Proactive 01/04
Pharma & Biotech Inside Biotech: Recce Pharmaceuticals advances late-stage push in antibiotic resistance fight By Proactive 01/04
Manufacturing & engineering Week ahead: Payrolls test looms as oil prices keep investors on edge By Proactive 30/03
Health Inside Biotech: Hormuz flashpoint jolts helium supply, squeezing MRI capacity By Proactive 30/03
Retail & consumer ASX 200 Hourly: ASX to open lower; Australia to avoid recession; National Cabinet to meet By Proactive 30/03
Battery Metals US and allies push rare earths, lithium supply chains but structural hurdles remain By Proactive 27/03
Oil & Gas Polymarket bettors put 62% odds on US forces entering Iran by April 30 as oil traders brace for $200 a barrel By Proactive 27/03
Pharma & Biotech Inside Biotech: Radiopharm advances RAD 402 into clinic with first patient dosed in Phase 1 trial By Proactive 27/03
